Theravance Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Weiss Asset Management LP BIP GP LLC WAM GP LLC Andrew M. Weiss Ph.D.(Weiss Asset Management LP 15.5%)

SEC announcement · Mar 5 22:02

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Theravance Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Weiss Asset Management LP BIP GP LLC WAM GP LLC Andrew M. Weiss Ph.D.(Weiss Asset Management LP  15.5%)

Risk Disclaimer

Theravance Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Weiss Asset Management LP BIP GP LLC WAM GP LLC Andrew M. Weiss Ph.D.(Weiss Asset Management LP 15.5%)